Autor según el artículo: Murcia, JM; González-Comeche, J; Marín, A; Barberán, J; Granizo, JJ; Aguilar, L; González-Moreno, J; González-Pina, B; López-Dupla, M; Irurzun, J
Departamento: Medicina i Cirurgia
Autor/es de la URV: López Dupla, Jesús Miguel / Vidal Marsal, Francisco
Palabras clave: Therapy Retrospective study Nursing homes Necrosis-factor-alpha Monoclonal-antibody Hospital practice Guidelines Gamma-interferon Ertapenem Elderly Ceftriaxone Cap Adults
Resumen: To evaluate in routine hospital practice the clinical response to ertapenem in comparison with other parenteral antibiotics in the treatment of community-acquired pneumonia (CAP), clinical records from patients with severe CAP treated with ertapenem from July 2002 to June 2006 in seven Spanish hospitals were retrospectively reviewed. Patients were classified according to the Pneumonia Severity Index (PSI). Each ertapenem-treated patient was matched with two patients in the same hospital treated with other antibiotics, according to age (difference <or=5 years), same PSI class and whether or not resident in a nursing home. Seventy-one patients treated with ertapenem and 131 matched controls were identified; 71 of the 202 patients came from nursing homes. A larger (p 0.0002) number of patients were treated with monotherapy in the ertapenem group. In total, 174 patients (86.1%) belonged to PSI classes IV-V; a higher (p <0.0001) PSI score was found in patients from nursing homes. The mean age was 80.5 years (75% of patients >76 years). Comorbidities were present in 193 patients (95.5%). No differences were found in median hospital stay (7 days for ertapenem vs. 10 days for comparators, p 0.066). A slightly higher clinical response rate was obtained for ertapenem vs. comparators (88.7% vs. 77.1%; p 0.0465; OR 2.25; 95% CI 0.99-5.12), with significant differences in clinical response in patients coming from nursing homes (95.8% ertapenem vs. 63.8% comparators; p 0.0034) but not in non-institutionalized patients (85.4% ertapenem vs. 84.5% comparators; p 0.929). The higher clinical response to ertapenem vs. comparators in severe CAP was due to its significantly higher efficacy in healthcare-associated CAP in patients coming from nursing homes.
Áreas temáticas: Saúde coletiva Química Odontología Microbiology (medical) Microbiology Medicine (miscellaneous) Medicina veterinaria Medicina iii Medicina ii Medicina i Interdisciplinar Infectious diseases Farmacia Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Ciências ambientais Ciências agrárias i Biotecnología Astronomia / física
Acceso a la licencia de uso: https://creativecommons.org/licenses/by/3.0/es/
ISSN: 1198743X
Direcció de correo del autor: jesusmiguel.lopez@urv.cat francesc.vidal@urv.cat
Identificador del autor: 0000-0002-9141-2523 0000-0002-6692-6186
Fecha de alta del registro: 2024-02-10
Versión del articulo depositado: info:eu-repo/semantics/submittedVersion
Enlace a la fuente original: https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(14)61801-2/fulltext
Referencia al articulo segun fuente origial: Clinical Microbiology And Infection. 15 (11): 1046-1050
Referencia de l'ítem segons les normes APA: Murcia, JM; González-Comeche, J; Marín, A; Barberán, J; Granizo, JJ; Aguilar, L; González-Moreno, J; González-Pina, B; López-Dupla, M; Irurzun, J (2009). Clinical response to ertapenem in severe community-acquired pneumonia: a retrospective series in an elderly population. Clinical Microbiology And Infection, 15(11), 1046-1050. DOI: 10.1111/j.1469-0691.2009.02843.x
URL Documento de licencia: https://repositori.urv.cat/ca/proteccio-de-dades/
DOI del artículo: 10.1111/j.1469-0691.2009.02843.x
Entidad: Universitat Rovira i Virgili
Año de publicación de la revista: 2009
Tipo de publicación: Journal Publications
Repositori URV